Skip to main content

Want a detailed portfolio tracker?

Heron Therapeutics (HRTX) P/E (2021 - 2026)

Heron Therapeutics (HRTX) P/E from Jun 30, 2021 to Jul 21, 2026. The TTM Heron Therapeutics (HRTX) P/E is -3.32. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Heron Therapeutics (HRTX)

YearP/EChange
2026-3.32-66.11%
2025-9.80+83.01%
2024-5.35+269.70%
2023-1.45+19.66%
2022-1.21-84.97%
2021-8.05N/A

Comparison Heron Therapeutics (HRTX) P/E with competitors

Heron Therapeutics (HRTX) P/E is -3.32.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.05%
NBYStablecoin Development Corp0.00-100.13%
ENLVEnlivex Ltd0.07-102.25%
FGENFibroGen Inc0.24-107.23%
CHRSCoherus Biosciences Inc0.85-125.55%
FBIOFortress Biotech Inc0.95-128.58%
ORMPOramed Pharmaceuticals Inc1.50-145.26%
AGENAgenus Inc3.01-190.62%
INVAInnoviva Inc3.15-194.97%
VXRTVaxart Inc3.55-206.88%
CRMDCorMedix Inc3.63-209.25%
CVACCureVac N.V.4.45-233.86%
GLPGGalapagos NV4.86-246.30%
SRPTSarepta Therapeutics Inc4.88-247.00%
ABEOAbeona Therapeutics Inc5.39-262.22%
ABUSArbutus Biopharma Corp5.60-268.48%
ZVRAZevra Therapeutics Inc5.89-277.26%
SPROSpero Therapeutics Inc6.23-287.54%
CGENCompugen Ltd6.31-290.11%
RIGLRigel Pharmaceuticals6.87-306.92%
SLXNSilexion Therapeutics Corp7.30-319.68%
OMEROmeros Corporation9.26-378.78%
AUPHAurinia Pharmaceuticals Inc9.58-388.60%
PLXProtalix BioTherapeutics Inc10.89-427.92%
ACADAcadia Pharmaceuticals Inc11.73-453.14%
TBPHTheravance Biopharma Inc12.26-469.21%
ADMAAdma Biologics Inc12.42-473.91%
HRMYHarmony Biosciences Holdings Inc13.82-516.12%
SABSSAB Biotherapeutics Inc14.14-525.64%
NAGENiagen Bioscience Inc14.82-546.17%
INCYIncyte Corp15.82-576.41%
REGNRegeneron Pharmaceuticals Inc15.86-577.44%
PBYIPuma Biotechnology Inc17.32-621.37%
CPRXCatalyst Pharmaceuticals Inc17.44-625.09%
EXELExelixis Inc17.54-628.07%
TGTXTG Therapeutics Inc18.97-671.06%
MDXGMimedx Group Inc20.55-718.83%
XOMAXOMA Royalty Corp22.87-788.77%
ARGXArgen X SE24.30-831.63%
CTMXCytomX Therapeutics Inc24.82-847.38%
XOMAOXOMA Royalty Corp25.34-863.15%
HALOHalozyme Therapeutics Inc25.62-871.54%
XOMAPXOMA Royalty Corp25.67-872.94%
VRTXVertex Pharmaceuticals Inc27.99-942.94%
RPRXRoyalty Pharma plc - Class A28.69-963.80%
SLNOSoleno Therapeutics Inc29.02-973.67%
ASNDAscendis Pharma A/S30.09-1005.89%
LGNDLigand Pharmaceuticals Inc - Class B37.91-1241.55%
APLSApellis Pharmaceuticals Inc39.02-1274.95%
BMRNBiomarin Pharmaceutical Inc42.21-1371.02%
KRYSKrystal Biotech Inc45.34-1465.32%
ONCBeiGene Ltd69.54-2193.90%
PHARPharming Group N.V.75.03-2359.06%
TECHBio-Techne Corp101.96-3170.03%
VCELVericel Corp109.92-3409.80%
ALNYAlnylam Pharmaceuticals Inc117.96-3652.00%
GMABGenmab140.29-4324.24%
TLXTelix Pharmaceuticals Ltd162.15-4982.52%
CORTCorcept Therapeutics Inc212.86-6509.26%